Novel Terahertz-Based Radiation Treatment of Alzheimer Disease

Abstract

Alzheimer’s Disease Facts and Figures, an annual report released by the Alzheimer’s Association, reveals the burden of Alzheimer’s and dementia on individuals, caregivers, government and the nation’s health care system. Per the special report, More Than Normal Aging: Understanding Mild Cognitive Impairment (MCI), it is estimated 10% to 15% of individuals with MCI go on to develop dementia each year. Because of the narrow brain-blood barrier every medicine designed to treat Alzheimer’s failed due to inability of complex and large molecules to penetrate this barrier. Four steps of Alzheimer’s treatment by using proprietary Magtera Technology. First step: Detect the THz modes for Aβ42 Oligomer. or any other micro bio structures proven to be responsible for Alzheimer’s. The most probable THz modes would be intermolecular modes: librations, low frequency bond vibrations; hydrogen bond stretches and distortions; molecular rotations. There are plenty of such modes. Second step: detect the THz modes of healthy brain tissue. Third step: Find a THz window of penetration in brain fluids that corresponds to one of these modes by using the highly tunable THz Magnon Laser that bridges the THz Gap and covers the whole THz spectrum. Fourth step: Apply high power THz radiation by using the THz Magnon Laser at resonance frequencies that correspond to Aβ42 Oligomer molecular excitations but do nor coincide with THz modes of healthy brain tissue, and eradicate Aβ42 Oligomer molecules.